In the work the theoretical and experimental solution of possible anti-Parkinson’s disease anaesthetic therapy was analysed from the group of dopamin’s receptors agonists (Bromocryptine) in combination with widespread nonnarcotic analgesics (sodium-diclophenak, nimesulide, celecoxibe, rofecoxibe, paracetamol and methamizol). It was established that Bromocryptine and its combinations with analgesics are able to influence the forming of central and peripheral component of nociceptive response in intacting animals.
